Phase II, open-label, multicenter study of combined intrathecal morphine and ziconotide: addition of ziconotide in patients receiving intrathecal morphine for severe chronic pain
(Q39321891)
scientific article
scientific article
Language:
other details
description | scientific article |
External Links
(P356) |
10.1111/J.1526-4637.2007.00355.X
|
(P698) |
18366507
|